PRIMAEGISresearch
← Scenarios
ACUTAAS

Acutaas Chemicals Limited

Pharmaceuticals: Major/ NSE
Compiled

Auto-generated from filings and public channels — no analyst dossier.

If management delivers what it guided

arithmetic on filed guidance and past valuations · not a price target
ACUTAAS
FY26 → FY28 · 2 years of guidance · ~1.7 years from today₹3,105 today
BEAR
₹2,772
-11%-7% a yr
14.4% a year · 48.6x exit
BASE
₹3,838
+24%+14% a yr
25% a year · 56.5x exit
BULL
₹6,334
+104%+54% a yr
34% a year · 81.1x exit
FY27FY28TODAY₹3,105 today₹6,334₹2,772₹3,838
Where the market has priced it
39x71x today96x
  • the guided figure reached earnings through a low-confidence bridge
  • FY27 one quarter filed — the pace is shown, not judged: guided +25.0%, filed +59.4% across 1 quarter(s)
  • this company's own median multiple sits 99% above its filed-industry peers; the scenario uses its own
How these numbers are produced
Earnings baseFY26 fiscal year EPS ₹43.51 (screener)
Guided growth25% a year, said on the call of 28-Jul-2026 · transcript
Read across asoperating: unlabelled growth figure, read as revenue — low confidence
Delivery calibration0.58x / 1x / 1.36x of what was guided — measured: 76 annual guided-vs-filed pairs + 77 near-complete quarterly years — NSE transcripts against the companies' own filings
Exit multiple48.64x / 56.46x / 81.1x, this company’s own p20 / median / p80 across 5 filed years
Filed-industry peersmedian 28.43x across 38 peers — the cross-check, not the input
Arithmeticbase EPS × (1 + guided growth × delivery)2 × exit multiple
Arithmetic on management’s own guidance and this company’s own past valuations. Not a price target, not a recommendation, and not a forecast of what the stock will do.

What management said

from NSE earnings-call filings · extracted, not interpreted
generic growth 25%
Abhishek Patel: We are still very much confident to deliver 25% growth rate for the revenue as confirmed by the CMD also.
Call 28-Jul-2026 · bridge confidence low · transcript PDF

Pace against its own guidance

FY27 one quarter filed — the pace is shown, not judged
guided 25.0% filed 59.4% 1 of 4 quarters